Kainic acid, prototypic kainate receptor agonist
Be the first to review this product! Submit a review
|
(79 Publications)
- Proven performance: cited in over 75 publications
- Available in different sizes to fit your experimental needs. Larger volume format available upon request
Product details
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Pathways
The GluR1-containing AMPA receptors participate significantly in the glutamatergic signaling pathway which is vital for fast excitatory synaptic transmission in the brain. This pathway also involves the NMDA receptors which work together with AMPA receptors to regulate synaptic plasticity and neuronal communication. Additionally the GluR1 interacts within the long-term potentiation (LTP) pathway contributing to the strengthening of synapses an essential mechanism underlying learning and memory.
Biological function summary
The GluR1 subunit is an essential component of the AMPA receptor complex which typically forms as a tetramer. This complex modulates synaptic strength and plasticity processes critical for learning and memory. The activity of AMPA receptors including those containing GluR1 is regulated by several auxiliary proteins and is essential for post-synaptic responses. The GluR1 subunit also interacts with other proteins such as TARPs which modulate its trafficking and channel properties.
Publications (79)
Recent publications for all applications. Explore the full list and refine your search
Acta physiologica (Oxford, England) 241:e70031 PubMed40165367
2025
Applications
Unspecified application
Species
Unspecified reactive species
Epilepsia 66:1703-1717 PubMed39932393
2025
Applications
Unspecified application
Species
Unspecified reactive species
CNS neuroscience & therapeutics 31:e70265 PubMed39924980
2025
Applications
Unspecified application
Species
Unspecified reactive species
F1000Research 12:47 PubMed39816762
2025
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11:e2407525 PubMed39476381
2024
Applications
Unspecified application
Species
Unspecified reactive species
Gene therapy 32:106-120 PubMed39455855
2024
Applications
Unspecified application
Species
Unspecified reactive species
Biomarker research 12:103 PubMed39272194
2024
Applications
Unspecified application
Species
Unspecified reactive species
Epilepsia open 9:1445-1457 PubMed38831626
2024
Applications
Unspecified application
Species
Unspecified reactive species
eNeuro 11: PubMed38641413
2024
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 6:1029 PubMed37821582
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com